Lundbeck LLC

Privately held: no public share price

Assets

(2 total)
2Total Assets
2Approved
0Phase 3 / Filed
0Phase 1–2 / Early
3Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
Approved
GABA-A receptorSmall molecule
EpilepsyDevelopmental and Epileptic EncephalopathiesLennox-Gastaut Syndrome
Approved
GABA transaminase (GABA-T)Small molecule
EpilepsyDevelopmental and Epileptic Encephalopathies
Focal Onset Seizures

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.